Medical Device Companies in France

A device that will be used in a French public hospital needs an EU MDR certificate, an ANSM-visible registration or vigilance path, and a place on a purchasing lot that AP-HP, a CHU groupement, UGAP or a GHT will actually award. That is a different commercial object from a CE mark that used to travel on a handshake. Capital equipment — imaging, anaesthesia, endoscopy, laboratory automation — is specified by the Pôle and the biomedical-engineering department, then purchased through a marché that the Assistance Publique or the regional CHU runs under public-procurement law. AP-HP’s central direction des achats is the densest single account in the country and still only covers Île-de-France university hospitals. Consumables, implants and IVD reagents ride a second path: LPPR listing for many outpatient and some inpatient devices, T2A bundling for the rest, and a distributeur who holds inventory in a French entrepôt. bioMérieux wins analyser-plus-reagent placements in CHU and private labs; Stago owns a large haemostasis installed base; Guerbet defends contrast-media and some interventional lines; Air Liquide Medical Systems sits on ventilation and medical-gas capital lists; Essilor’s instrument book sits in ophthalmology clinics more than in the CHU cath lab. Siemens, GE and Philips sell imaging with French field forces and still lose provincial lots when the service van is a Paris fiction. Private groups (Ramsay Santé, Elsan, Vivalto) buy on committee cycles that look more like IHH than like AP-HP. BioNixus reconstructs the named ANSM-visible file, the named marché and the named CHU or AP-HP desk before a France volume number is signed.

The accounts above are the ones our field teams and analysts work with. What a brand team typically commissions from us in France:

Matching listicle and country brief, sibling directories in France, and the same directory for neighbouring markets.